Arkolith/Insider Trading/ARTV/Form 4

Raymon Heather

SVP, Research and DevelopmentArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Aug 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2025Tax withholding(F)2K$2.75$5K41K
May 15, 2025Tax withholding(F)745$2.13$2K43K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-022223) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML